Literature DB >> 9405900

Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes.

A Avignon1, A Radauceanu, L Monnier.   

Abstract

OBJECTIVE: To evaluate the relative value of plasma glucose (PG) at different time points in assessing glucose control of type 2 diabetic patients. RESEARCH DESIGN AND METHODS: Glycemic profiles, i.e., PG at prebreakfast (8:00 A.M.), prelunch (11:00 A.M.), postlunch (2:00 P.M.), and extended postlunch (5:00 P.M.) times over the same day, were obtained in 66 type 2 diabetic patients on an ambulatory basis. The different time points of PG were compared with a measurement of HbA1c made in a reference laboratory.
RESULTS: Extended postlunch PG was lower than prebreakfast PG (104 +/- 21 vs. 133 +/- 35 mg/dl, P < 0.02) in patients demonstrating good diabetic control (HbA1c < or = 7.0%), was not different from prebreakfast PG (149 +/- 47 vs. 166 +/- 26 mg/dl, NS) in patients demonstrating fair diabetic control (7.0% < HbA1c < or = 8.5%), and was higher than prebreakfast PG (221 +/- 62 vs. 199 +/- 49 mg/dl, P < or = 0.01) in those demonstrating poor diabetic control (HbA1c < or = 8.5%). Prebreakfast, prelunch, postlunch, and extended postlunch PG values were all significantly correlated with HbA1c. Multiple linear regression analysis demonstrated that postlunch PG and extended postlunch PG correlated significantly and independently with HbA1c, but that prebreakfast PG and prelunch PG did not. Moreover, postlunch PG and extended postlunch PG demonstrated better sensitivity, specificity, and positive predictive value in predicting poor glycemic control than did prebreakfast PG or prelunch PG.
CONCLUSIONS: In type 2 diabetes, postlunch PG and extended postlunch PG are better predictors of glycemic control than fasting plasma glucose (FPG). We therefore suggest that they be more widely used to supplement, or substitute for, FPG in evaluating the metabolic control of type 2 diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9405900     DOI: 10.2337/diacare.20.12.1822

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  65 in total

Review 1.  Prandial glucose regulation in the glucose triad: emerging evidence and insights.

Authors:  Paul Beisswenger; Robert J Heine; Lawrence A Leiter; Alan Moses; Jaakko Tuomilehto
Journal:  Endocrine       Date:  2004-12       Impact factor: 3.633

2.  Fasting and post-prandial glycemia and their correlation with glycated hemoglobin in Type 2 diabetes.

Authors:  M Monami; C Lamanna; L Lambertucci; R Longo; C Cocca; F Addante; E Lotti; G Masotti; N Marchionni; E Mannucci
Journal:  J Endocrinol Invest       Date:  2006 Jul-Aug       Impact factor: 4.256

3.  Glycaemic control is improved by 7 days of aerobic exercise training in patients with type 2 diabetes.

Authors:  C R Mikus; D J Oberlin; J Libla; L J Boyle; J P Thyfault
Journal:  Diabetologia       Date:  2012-02-04       Impact factor: 10.122

4.  Self-monitoring of blood glucose with finger tip versus alternative site sampling: effect on glycemic control in insulin-using patients with type 2 diabetes.

Authors:  Philip E Knapp; Kara M Showers; Jenna C Phipps; Jeanne L Speckman; Elliot Sternthal; Karen M Freund; Arlene S Ash; Caroline M Apovian
Journal:  Diabetes Technol Ther       Date:  2009-04       Impact factor: 6.118

Review 5.  Food protein-derived bioactive peptides in management of type 2 diabetes.

Authors:  Prasad Patil; Surajit Mandal; Sudhir Kumar Tomar; Santosh Anand
Journal:  Eur J Nutr       Date:  2015-07-08       Impact factor: 5.614

6.  The correlation of hemoglobin A1c to blood glucose.

Authors:  Ken Sikaris
Journal:  J Diabetes Sci Technol       Date:  2009-05-01

Review 7.  Insulin analogs or premixed insulin analogs in combination with oral agents for treatment of type 2 diabetes.

Authors:  Philip Levy
Journal:  MedGenMed       Date:  2007-04-16

8.  Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus.

Authors:  E Bonora; G Corrao; V Bagnardi; A Ceriello; M Comaschi; P Montanari; J B Meigs
Journal:  Diabetologia       Date:  2006-03-11       Impact factor: 10.122

9.  Associations between features of glucose exposure and A1C: the A1C-Derived Average Glucose (ADAG) study.

Authors:  Rikke Borg; Judith C Kuenen; Bendix Carstensen; Hui Zheng; David M Nathan; Robert J Heine; Jorn Nerup; Knut Borch-Johnsen; Daniel R Witte
Journal:  Diabetes       Date:  2010-04-27       Impact factor: 9.461

10.  Improvement of glucose metabolism in patients with impaired glucose tolerance or diabetes by long-term administration of a palatinose-based liquid formula as a part of breakfast.

Authors:  Masae Sakuma; Hidekazu Arai; Akira Mizuno; Makiko Fukaya; Motoi Matsuura; Hajime Sasaki; Hisami Yamanaka-Okumura; Hironori Yamamoto; Yutaka Taketani; Toshio Doi; Eiji Takeda
Journal:  J Clin Biochem Nutr       Date:  2009-08-28       Impact factor: 3.114

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.